BEAM
Price
$25.70
Change
+$1.10 (+4.47%)
Updated
Oct 9 closing price
Capitalization
2.5B
29 days until earnings call
Intraday BUY SELL Signals
IBB
Price
$206.49
Change
+$6.01 (+3.00%)
Updated
Oct 9 closing price
Net Assets
10.41B
Intraday BUY SELL Signals
Interact to see
Advertisement

BEAM vs IBB

BEAM vs IBB Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BEAM vs. IBB commentary
Oct 11, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and IBB is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
BEAM: Fundamental Ratings
BEAM
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMIBB
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 13 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 6 days ago
90%
COMPARISON
Comparison
Oct 11, 2026
Stock price -- (BEAM: $25.70)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green while .

  • BEAM’s FA Score: 1 green, 4 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish.

  • BEAM’s TA Score: 6 bullish, 5 bearish.

Price Growth

BEAM (@Biotechnology) experienced а +4.90% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.51%. For the same industry, the average monthly price growth was -13.43%, and the average quarterly price growth was -4.26%.

Reported Earning Dates

BEAM is expected to report earnings on Nov 09, 2026.

Industries' Descriptions

@Biotechnology (-2.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
BEAM
Daily Signal:
Gain/Loss:
IBB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XYZG15.740.84
+5.62%
Leverage Shares 2X Long XYZ Daily ETF (XYZG)
MYI9.570.10
+1.06%
Blackrock Muniyield Quality Fund III
VEGA52.980.24
+0.46%
AdvisorShares STAR Global Buy-Write ETF (VEGA)
MBND25.600.05
+0.18%
State Street Nuveen Municipal Bond ETF (MBND)
SNDU21.09-0.77
-3.52%
T-REX 2X Long SNDK Daily Target ETF (SNDU)

IBB and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBB has been closely correlated with VRTX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if IBB jumps, then VRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBB
1D Price
Change %
IBB100%
+3.00%
VRTX - IBB
67%
Closely correlated
+1.36%
CRSP - IBB
63%
Loosely correlated
+5.85%
AMGN - IBB
61%
Loosely correlated
+1.82%
EDIT - IBB
60%
Loosely correlated
+2.11%
BEAM - IBB
58%
Loosely correlated
+4.47%
More